Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials

Journal article

Peer reviewed

David N Assis and Cynthia Levy

Hepatology (Baltimore, Md.), Vol.73(3), pp.887-889

2021-03

PMID: 33403699

Metrics

5 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.125 Hepatitis; 1.125.1515 Primary Biliary Cirrhosis
Web Of Science research areas: Gastroenterology & Hepatology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials
Creators: David N Assis - Department of Medicine, Section of Digestive Diseases Yale School of Medicine New Haven CT
Cynthia Levy - Division of Digestive Health and Liver Diseases University of Miami Miami FL
Publication Details: Hepatology (Baltimore, Md.), Vol.73(3), pp.887-889
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
PMID: 33403699
Record Identifier: 991031599410702976